Issue 3, 2018

Nanoparticles of metal–organic cages designed to encapsulate platinum-based anticancer agents

Abstract

We present a novel design to use metal–organic cages (MOCs) to encapsulate Pt-based anticancer agents for delivery. A fluorescein-conjugated Pt(IV) prodrug of cisplatin is developed for its encapsulation in a cationic MOC via host–guest interactions, which then forms drug-loaded nanoparticles with an anionic polymer.

Graphical abstract: Nanoparticles of metal–organic cages designed to encapsulate platinum-based anticancer agents

Supplementary files

Article information

Article type
Communication
Submitted
20 Sep 2017
Accepted
07 Dec 2017
First published
07 Dec 2017

Dalton Trans., 2018,47, 670-674

Nanoparticles of metal–organic cages designed to encapsulate platinum-based anticancer agents

Z. Yue, H. Wang, D. J. Bowers, M. Gao, M. Stilgenbauer, F. Nielsen, J. T. Shelley and Y. Zheng, Dalton Trans., 2018, 47, 670 DOI: 10.1039/C7DT03537C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements